Precision. Passion.

ProCure's mission is to improve the lives of patients with cancer by increasing access to proton therapy.


Media Contact: Lara Siegel, BlissHealth



Proton Therapy Center in New Jersey Recognized at the 52nd Annual New Good Neighbor Awards

SOMERSET, N.J. (July 23, 2012) – - The ProCure Proton Therapy Center in Somerset, N.J. was awarded the “New Good Neighbor Award” by the New Jersey Business & Industry Association and New Jersey Business magazine. One of eight companies to earn the honor at the 52nd Annual Good Neighbor Award Ceremony earlier this month, ProCure was recognized for its contribution to the economic value of the community, as well as for its noteworthy investment in the fight against cancer in New Jersey.

“We are thrilled to be recognized by such prestigious panel members and organizations. The award is an acknowledgement of ProCure’s mission to improve the lives of patients with cancer by increasing access to proton therapy,” said James Jarrett, president of the center. “New Jersey has welcomed us with open arms. We are excited to be a part of the economic landscape of the state and to provide this advanced cancer treatment to patients.”

ProCure broke ground on its New Jersey center in April 2010 and opened its doors in March 2012- reflecting a record-breaking process of only 23 months. The facility’s development created 400 local construction jobs, and the center currently employs 100 full-time staff members. At full capacity, the center will be able to treat 1,500 patients each year.

“ProCure’s decision to open in Somerset demonstrates the county’s determination to diversify its economy,” said Mike Kerwin, president of the Somerset County Business Partnership. “ProCure has placed Somerset County in the unique position of being home to the 10th proton therapy center in the nation. Because of this, I was proud to nominate ProCure for this award. Somerset is truly grateful to ProCure’s initiation and contribution to the community,” Kerwin said.

Cancer is the second-leading cause of death in New Jersey. It’s estimated that approximately 49,000 New Jersey residents and more than 107,000 New York residents will be diagnosed with cancer each year. Proton therapy offers an unmatched combination of power and precision. Protons deliver a high dose of cancer stopping energy while emitting up to 80 percent less radiation to healthy tissue and minimizing short- and long-term side effects of standard radiation.

Studies have shown proton therapy to be effective in treating many types of tumors, including brain, central nervous system, gastrointestinal, head and neck, lung and prostate, as well as sarcomas and many pediatric cancers.

For more information about the center, visit or call 732-204-7398.

About ProCure Treatment Centers, Inc.

ProCure Treatment Centers, Inc. is a privately held health care company dedicated to improving the lives of patients with cancer by increasing access to proton therapy. The company was founded in 2005 in Bloomington, Ind., and is the first to develop a network of proton therapy centers in cities across the United States. The ProCure Proton Therapy Center in Oklahoma City opened in July 2009, the CDH Proton Center, A ProCure Center, located in Warrenville, Ill., opened in October 2010 and the ProCure Proton Therapy Center in Somerset, N.J., opened in March 2012. ProCure’s fourth center is under construction in Seattle, Wash. (opening 2013) and others are in development. ProCure provides management leadership and a comprehensive approach for the design, construction, financing, staffing, training and day-to-day operations of proton therapy centers. ProCure’s solution reduces the time, cost and effort necessary to build and operate a facility. ProCure is advancing proton therapy through innovation and improvements in technology, and by providing training at the world’s only educational facility specializing in proton therapy. For more information, visit